Who
Robert J. Hariri
Director
Company insider
Files Form 4 as: Director, CryoPort; Chief Executive Officer, Celularity; Director, BioVie; Director and 10% owner, Myos Rens Technology; Director, Bionik Laboratories; Director, WaferGen Bio-systems; Director, Ir Biosciences Holdings.
In numbers
- Trades disclosed
- 137
- Buys
- 27
- Sells
- 11
- Bought
- $3.5M
- Sold
- $541K
- Companies
- 7
- Companies where not an officer
- 6
- First trade
- 1 Aug 2007
- Last trade
- 5 Jun 2026
- Last filed
- 8 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Jun 2026filed 8 Jun 2026 | CYRX CryoPortLife-science tools | SEC FORM 4 Code A | —10,350 at $0.00 | filing |
| 5 Jun 2026filed 8 Jun 2026 | CYRX CryoPortoption or derivative · Life-science tools | SEC FORM 4 Code A | —16,077 at $0.00 | filing |
| 5 Jun 2026filed 8 Jun 2026 | CYRX CryoPortoption or derivative · Life-science tools | SEC FORM 4 Code A | —16,077 at $0.00 | filing |
| 5 Jun 2026filed 8 Jun 2026 | CYRX CryoPortLife-science tools | SEC FORM 4 Code A | —10,350 at $0.00 | filing |
| 13 Apr 2026filed 15 Apr 2026 | CELU CelularityBiotechnology | SEC FORM 4 Code M | —3,281 at $0.00 | filing |
| 13 Apr 2026filed 15 Apr 2026 | CELU CelularityBiotechnology | SEC FORM 4 Code F | $1,5131,182 at $1.28 | filing |
| 13 Apr 2026filed 15 Apr 2026 | CELU Celularityoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,281 at $0.00 | filing |
| 13 Apr 2026filed 15 Apr 2026 | CELU Celularityoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,281 at $0.00 | filing |
| 13 Apr 2026filed 15 Apr 2026 | CELU CelularityBiotechnology | SEC FORM 4 Code M | —3,281 at $0.00 | filing |
| 13 Apr 2026filed 15 Apr 2026 | CELU CelularityBiotechnology | SEC FORM 4 Code F | $1,5131,182 at $1.28 | filing |
| 11 Sep 2025filed 12 Sep 2025 | CYRX CryoPortoption or derivative · Life-science tools | SEC FORM 4 Code M | —50,000 at $0.00 | filing |
| 11 Sep 2025filed 12 Sep 2025 | CYRX CryoPortLife-science tools | SEC FORM 4 Code M | $133K50,000 at $2.66 | filing |
| 11 Sep 2025filed 12 Sep 2025 | CYRX CryoPortLife-science tools | SEC FORM 4 Sold | $243K25,000 at $9.71 | filing |
| 22 Aug 2025filed 29 Aug 2025 | CYRX CryoPortLife-science tools | SEC FORM 4 Sold | $43K5,000 at $8.60 | filing |
| 6 Jun 2025filed 10 Jun 2025 | CYRX CryoPortoption or derivative · Life-science tools | SEC FORM 4 Code A | —41,098 at $0.00 | filing |
| 6 Jun 2025filed 10 Jun 2025 | CYRX CryoPortLife-science tools | SEC FORM 4 Code A | —23,214 at $0.00 | filing |
| 28 May 2025filed 30 May 2025 | CYRX CryoPortLife-science tools | SEC FORM 4 Sold | $76K12,500 at $6.10 | filing |
| 13 Apr 2025filed 4 Jun 2025 | CELU Celularityoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,281 at $0.00 | filing |
| 13 Apr 2025filed 4 Jun 2025 | CELU CelularityBiotechnology | SEC FORM 4 Code M | —3,281 at $0.00 | filing |
| 13 Apr 2025filed 4 Jun 2025 | CELU CelularityBiotechnology | SEC FORM 4 Code F | $1,8931,154 at $1.64 | filing |
News
Head to Head Review: CryoPort (NASDAQ:CYRX) & iSpecimen (NASDAQ:ISPC)CYRX · dailypolitical.com · 18 Oct 2026
0 headlines in the last 90 days name Robert J. Hariri; 1 article from the last 14 days about the 2 companies they traded most, at most three about any one of them.